I like your post… Your absolutely right… we ha
Post# of 151626

Once the safety aggregate is complete with honors and trials restored with information happening on multiple fronts on these great indications… we should be seeing big changes… or not.
Why… is the question… interesting enough is the ability to overlook Leronlimab’s potential. Yet… nobody can explain well enough for me why we have so little value. It’s a crying shame isn’t it…

